C3 glomerulopathy post kidney transplantation: A single center experience

doi:10.5500/wjt.v15.i2.101517

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (18)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-2)

Sum=16

Jun 18, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Transplant. Jun 18, 2025; 15(2): 101517
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.101517

Full Size Figure Download Figure

Figure 3 Death censored allograft survival from index biopsy in C3 glomerulopathies recurrence untreated and treated cohorts. The patients in the treatment cohort received steroids (n = 1), eculizumab (n = 4), or eculizumab and plasmapheresis (n = 2). P = 0.003, log-rank test.

Citation: Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL. C3 glomerulopathy post kidney transplantation: A single center experience. World J Transplant 2025; 15(2): 101517
URL: https://www.wjgnet.com/2220-3230/full/v15/i2/101517.htm
DOI: https://dx.doi.org/10.5500/wjt.v15.i2.101517